|
|
|
|
|
|
Antibiotics used for hospital-acquired pneumonia include aminoglycosides, fluoroquinolones, carbapenems, and vancomycin. Multiple antibiotics are administered in combination in order to cover all the possible organisms effectively and rapidly, before the infectious agent can be known. Antibiotic choice varies from hospital to hospital as the likely pathogens and resistance patterns vary similarly. Pneumonia is an infectious disease by definition, and whether a patient is prone to develop pneumonia depends on the presence of pathogens but equally on the patient's immune system and other factors. Most pneumonias are not epidemic, although infection with influenza virus can be so defined. Breathing problems, as often present in patients after a stroke, in Parkinson's disease, hospitalisation or surgery and mechanical ventilation can all increase the likelihood of pneumonia. In Europe, deaths from TB fell from 500 out of 100,000 in 1850 to 50 out of 100,000 by 1950. Improvements in public health were reducing tuberculosis even before the arrival of antibiotics, although the disease's significance was still such that when the Medical Research Council was formed in Britain in 1913 its first project was tuberculosis. It was not until 1946 with the development of the antibiotic streptomycin that treatment rather than prevention became a possibility. Prior to then only surgical intervention was possible as supposed treatment (other than sanatoria), including the pneumothorax technique: collapsing an infected lung to 'rest' it and allow lesions to heal, which was an accomplished technique but was of little benefit and was discontinued after 1946. Click on following items to see more information: Acinetobacter, Antimicrobials, Antibiotics, Antibiotics, Antimicrobials, Bacillus, Microorganism, Microorganism, Bactericidal, Microorganisms, Biofilms, Campylobacter, Cell cultures, Citrobacter, Cryptococci, Escherichia coli, Escherichia coli, Escherichia coli, Escherichia coli, Escherichia coli, Escherichia coli, Erythromycin, Yeasts, Yeasts, Haemophilus, Lactobacillus, Meningococcus, Microbial, Microflora, Multidrug resistant, Pediococci, Prokaryotes, Pseudomonas aeruginosa, S. cerevisiae, S. cerevisiae, Salmonella, Salmonella, Staphylococcus, Staphylococcus, Streptococci, Streptomycin, Water purification Until recently, while we could study specific types of bacteria, we lacked a cohesive classification system, so that we could not readily predict the properties of one species based on the known properties of others. Visual appearance, which is the basis for classification of large organisms, simply does not work with many microbes because there are few distinguishing characteristics for comparison between species even under the microscope. However, analysis of their genetic material in the past 20 years has allowed such classification and spawned a revolution in our thinking about the evolution of bacteria and all other species. The emergence of a new system organizing life on Earth into three domains is attributable to this pioneering work with microorganisms. Sergei Winogradsky was also interested in soil bacteria, especially those involved in the cycling of nitrogen and sulfur compounds. He was one of the first to isolate microorganisms responsible for the conversion of these elements in the soil, obtaining pure cultures of bacteria capable of the conversion of ammonia to nitrate by microorganisms in the soil. Winogradsky also studied the consumption of hydrogen sulfide gas by sulfur-oxidizing bacteria directly in their natural habitat.
|
© 2005
Transgalactic Ltd (manufacturer of Bioscreen C software) |
Privacy Statement | P.O. Box
1393, 00101 Helsinki, Finland,
Last modified: May 25, 2005
| ||||||
